Literature DB >> 33834394

The Application of a Machine Learning-Based Brain Magnetic Resonance Imaging Approach in Major Depression.

Kyoung-Sae Na1, Yong-Ku Kim2.   

Abstract

Major depressive disorder (MDD) shows a high prevalence and is associated with increased disability. While traditional studies aimed to investigate global characteristic neurobiological substrates of MDD, machine learning-based approaches focus on individual people rather than a group. Therefore, machine learning has been increasingly conducted and applied to clinical practice. Several previous neuroimaging studies used machine learning for stratifying MDD patients from healthy controls as well as in differentially diagnosing MDD apart from other psychiatric disorders. Also, machine learning has been used to predict treatment response using magnetic resonance imaging (MRI) results. Despite the recent accomplishments of machine learning-based MRI studies, small sample sizes and the heterogeneity of the depression group limit the generalizability of a machine learning-based predictive model. Future neuroimaging studies should integrate various materials such as genetic, peripheral, and clinical phenotypes for more accurate predictability of diagnosis and treatment response.

Entities:  

Keywords:  Depression; MRI; Machine learning; Neuroimaging

Mesh:

Year:  2021        PMID: 33834394     DOI: 10.1007/978-981-33-6044-0_4

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  42 in total

1.  Brain grey matter abnormalities in medication-free patients with major depressive disorder: a meta-analysis.

Authors:  Y-J Zhao; M-Y Du; X-Q Huang; S Lui; Z-Q Chen; J Liu; Y Luo; X-L Wang; G J Kemp; Q-Y Gong
Journal:  Psychol Med       Date:  2014-03-21       Impact factor: 7.723

Review 2.  Machine Learning in Medicine.

Authors:  Alvin Rajkomar; Jeffrey Dean; Isaac Kohane
Journal:  N Engl J Med       Date:  2019-04-04       Impact factor: 91.245

3.  Global hippocampal atrophy in major depressive disorder: a meta-analysis of magnetic resonance imaging studies.

Authors:  Marcelo Antônio Oliveira Santos; Lucas Soares Bezerra; Ana Rita Marinho Ribeiro Carvalho; Alessandra Mertens Brainer-Lima
Journal:  Trends Psychiatry Psychother       Date:  2018-09-17

4.  Voxel-Based Meta-Analytical Evidence of Structural Disconnectivity in Major Depression and Bipolar Disorder.

Authors:  Toby Wise; Joaquim Radua; Gareth Nortje; Anthony J Cleare; Allan H Young; Danilo Arnone
Journal:  Biol Psychiatry       Date:  2015-03-12       Impact factor: 13.382

5.  Hippocampal volume and depression: a meta-analysis of MRI studies.

Authors:  Poul Videbech; Barbara Ravnkilde
Journal:  Am J Psychiatry       Date:  2004-11       Impact factor: 18.112

6.  Immunohistochemical demonstration of glial fibrillary acidic protein in scrapie.

Authors:  A Mackenzie
Journal:  J Comp Pathol       Date:  1983-04       Impact factor: 1.311

7.  Detecting Neuroimaging Biomarkers for Depression: A Meta-analysis of Multivariate Pattern Recognition Studies.

Authors:  Joseph Kambeitz; Carlos Cabral; Matthew D Sacchet; Ian H Gotlib; Roland Zahn; Mauricio H Serpa; Martin Walter; Peter Falkai; Nikolaos Koutsouleris
Journal:  Biol Psychiatry       Date:  2016-11-09       Impact factor: 13.382

8.  Conjoint and dissociated structural and functional abnormalities in first-episode drug-naive patients with major depressive disorder: a multimodal meta-analysis.

Authors:  Weina Wang; Youjin Zhao; Xinyu Hu; Xiaoqi Huang; Weihong Kuang; Su Lui; Graham J Kemp; Qiyong Gong
Journal:  Sci Rep       Date:  2017-09-04       Impact factor: 4.379

Review 9.  Diagnostic Value of Salivary Markers in Neuropsychiatric Disorders.

Authors:  Agnieszka Kułak-Bejda; Napoleon Waszkiewicz; Grzegorz Bejda; Anna Zalewska; Mateusz Maciejczyk
Journal:  Dis Markers       Date:  2019-05-02       Impact factor: 3.434

Review 10.  Machine learning in major depression: From classification to treatment outcome prediction.

Authors:  Shuang Gao; Vince D Calhoun; Jing Sui
Journal:  CNS Neurosci Ther       Date:  2018-08-23       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.